{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262944561051776.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1021/jm500531z"}},{"identifier":{"@type":"URI","@value":"https://pubs.acs.org/doi/pdf/10.1021/jm500531z"}}],"dc:title":[{"@value":"Development and Bioorthogonal Activation of Palladium-Labile Prodrugs of Gemcitabine"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262944561051778","@type":"Researcher","foaf:name":[{"@value":"Jason T. Weiss"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561051904","@type":"Researcher","foaf:name":[{"@value":"John C. Dawson"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561051780","@type":"Researcher","foaf:name":[{"@value":"Craig Fraser"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561051782","@type":"Researcher","foaf:name":[{"@value":"Witold Rybski"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561051777","@type":"Researcher","foaf:name":[{"@value":"Carmen Torres-Sánchez"}],"jpcoar:affiliationName":[{"@value":"Wolfson\rSchool of Mechanical and Manufacturing Engineering, Loughborough University, Loughborough LE11 3TU, U.K."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561051776","@type":"Researcher","foaf:name":[{"@value":"Mark Bradley"}],"jpcoar:affiliationName":[{"@value":"School\rof Chemistry, University of Edinburgh, West Mains Road, Edinburgh EH9 3JJ, U.K."}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561051905","@type":"Researcher","foaf:name":[{"@value":"E. Elizabeth Patton"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561051779","@type":"Researcher","foaf:name":[{"@value":"Neil O. Carragher"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262944561051781","@type":"Researcher","foaf:name":[{"@value":"Asier Unciti-Broceta"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00222623"},{"@type":"EISSN","@value":"15204804"}],"prism:publicationName":[{"@value":"Journal of Medicinal Chemistry"}],"dc:publisher":[{"@value":"American Chemical Society (ACS)"}],"prism:publicationDate":"2014-06-12","prism:volume":"57","prism:number":"12","prism:startingPage":"5395","prism:endingPage":"5404"},"reviewed":"false","dc:rights":["http://pubs.acs.org/page/policy/authorchoice_termsofuse.html"],"url":[{"@id":"https://pubs.acs.org/doi/pdf/10.1021/jm500531z"}],"createdAt":"2014-05-27","modifiedAt":"2023-04-22","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050566774754140928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Biotransporting Biocatalytic Reactors Toward Therapeutic Nanofactories"}]},{"@id":"https://cir.nii.ac.jp/crid/1360011146124003456","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"In Vivo Gold Complex Catalysis within Live Mice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025431115766656","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Catalytic Activity Alternation of an Artificial Metalloenzyme by Switchable Binding to the Proteins"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092422329472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Bioorthogonal release of anticancer drugs <i>via</i> gold-triggered 2-alkynylbenzamide cyclization"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118821774208","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression"}]},{"@id":"https://cir.nii.ac.jp/crid/1360848658069655040","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Targeting and Treatment of Tumor Hypoxia by Newly Designed Prodrug Possessing High Permeability in Solid Tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1360857593746769152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"In vivo organic synthesis by metal catalysts"}]},{"@id":"https://cir.nii.ac.jp/crid/1361412889524526592","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"A Hydrogen Peroxide Activatable Gemcitabine Prodrug for the Selective Treatment of Pancreatic Ductal Adenocarcinoma"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1021/jm500531z"},{"@type":"CROSSREF","@value":"10.1002/cctc.202500154_references_DOI_3RthHFyjUBpNXNQ5AqvAbOK8FJA"},{"@type":"CROSSREF","@value":"10.1002/anie.201610273_references_DOI_3RthHFyjUBpNXNQ5AqvAbOK8FJA"},{"@type":"CROSSREF","@value":"10.1039/d0sc04329j_references_DOI_3RthHFyjUBpNXNQ5AqvAbOK8FJA"},{"@type":"CROSSREF","@value":"10.1038/s41467-021-27804-5_references_DOI_3RthHFyjUBpNXNQ5AqvAbOK8FJA"},{"@type":"CROSSREF","@value":"10.1002/advs.201800801_references_DOI_3RthHFyjUBpNXNQ5AqvAbOK8FJA"},{"@type":"CROSSREF","@value":"10.1021/acs.molpharmaceut.6b00011_references_DOI_3RthHFyjUBpNXNQ5AqvAbOK8FJA"},{"@type":"CROSSREF","@value":"10.1016/j.bmc.2021.116353_references_DOI_3RthHFyjUBpNXNQ5AqvAbOK8FJA"},{"@type":"CROSSREF","@value":"10.1002/cmdc.201900324_references_DOI_3RthHFyjUBpNXNQ5AqvAbOK8FJA"}]}